Lunai Bioworks Inc.

Name: Lunai Bioworks Inc. standardized financial statements, quarterly
Creator: Listed

LNAINasdaqCIK 1527728HealthcareFiscal year ends Jun 30

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$31.1k, Q4 FY2026

Operating income−$2.1m, Q4 FY2026

Net income−$2.0m, Q4 FY2026

Lunai Bioworks Inc., income statement, quarterly
Line item	Unit	Q1 FY20242023-09-30	Q2 FY20242023-12-31	Q3 FY20242024-03-31	Q4 FY20242024-06-30	Q1 FY20252024-09-30	Q2 FY20252024-12-31	Q3 FY20252025-03-31	Q4 FY20252025-06-30	Q1 FY20262025-09-30	Q2 FY20262025-12-31	Q3 FY20262026-03-31	Q4 FY20262026-06-30
Revenue	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	0.0	0.0
Cost of revenue	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Gross profit	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	0.0	not reported
Research and development	$m	0.6	0.6	1.1	0.4	0.4	0.2	not reported	not reported	0.0	0.0	0.0	(0.1)
Operating income	$m	(8.9)	(4.3)	(51.4)	(17.1)	(53.3)	(4.5)	(4.2)	(127)	(3.3)	(1.8)	(1.5)	(2.1)
Interest expense	$m	0.2	0.3	0.3	0.3	0.3	0.1	0.2	0.2	0.1	0.1	0.1	(0.1)
Income tax	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Net income	$m	(9.2)	(4.5)	(59.0)	(15.7)	(44.2)	(7.3)	0.2	(127)	2.8	(1.8)	(2.6)	(2.0)
Diluted EPS	$ per share	(0.14)	(0.07)	(0.54)	not reported	(2.76)	(0.45)	0.00	not reported	0.13	(0.08)	(0.10)	not reported
Basic EPS	$ per share	(0.14)	(0.07)	(0.54)	not reported	(2.76)	(0.45)	0.00	not reported	0.13	(0.08)	(0.10)	not reported

Balance sheet

Cash and equivalents$1.7m, FY2026

Shareholders' equity−$9.0m, FY2026

Lunai Bioworks Inc., balance sheet, quarterly
Line item	Unit	Q1 FY20242023-09-30	Q2 FY20242023-12-31	Q3 FY20242024-03-31	FY20242024-06-30	Q1 FY20252024-09-30	Q2 FY20252024-12-31	Q3 FY20252025-03-31	FY20252025-06-30	Q1 FY20262025-09-30	Q2 FY20262025-12-31	Q3 FY20262026-03-31	FY20262026-06-30
Cash and equivalents	$m	0.5	0.2	0.3	0.2	0.2	0.3	0.9	0.1	0.6	0.5	3.2	1.7
Current assets	$m	1.9	2.4	1.2	2.0	1.9	1.7	3.7	1.0	0.8	0.5	3.7	2.0
Total assets	$m	57.6	58.0	178	163	122	111	118	8.2	7.0	6.7	9.9	9.9
Current liabilities	$m	10.1	13.8	20.9	30.3	23.0	28.6	28.8	29.2	19.7	20.0	19.3	18.9
Total liabilities	$m	10.8	14.4	43.7	31.2	23.7	29.3	29.3	29.6	20.0	20.2	19.4	19.0
Long-term debt	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Current portion of debt	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Short-term borrowings	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Shareholders' equity	$m	46.7	43.6	134	132	98.1	82.1	88.4	(21.3)	(13.0)	(13.5)	(9.6)	(9.0)

Cash flow

Operating cash flow−$1.8m, Q4 FY2026

Capital expenditure$0, Q4 FY2026

Lunai Bioworks Inc., cash flow, quarterly
Line item	Unit	Q1 FY20242023-09-30	Q2 FY20242023-12-31	Q3 FY20242024-03-31	Q4 FY20242024-06-30	Q1 FY20252024-09-30	Q2 FY20252024-12-31	Q3 FY20252025-03-31	Q4 FY20252025-06-30	Q1 FY20262025-09-30	Q2 FY20262025-12-31	Q3 FY20262026-03-31	Q4 FY20262026-06-30
Operating cash flow	$k	(2,777)	(3,147)	(2,634)	(2,414)	(2,016)	(2,560)	(1,487)	(1,811)	(1,349)	(1,071)	(1,027)	(1,841)
Capital expenditure	$k	not reported	not reported	5.3	23.6	not reported	not reported	not reported	not reported	not reported	not reported	0.0	0.0

Diluted shares (weighted)24.99m, Q3 FY2026

Lunai Bioworks Inc., shares, quarterly
Line item	Unit	Q1 FY20232022-09-30	Q2 FY20232022-12-31	Q3 FY20232023-03-31	Q1 FY20242023-09-30	Q2 FY20242023-12-31	Q3 FY20242024-03-31	Q1 FY20252024-09-30	Q2 FY20252024-12-31	Q3 FY20252025-03-31	Q1 FY20262025-09-30	Q2 FY20262025-12-31	Q3 FY20262026-03-31
Diluted shares (weighted)	m shares	55.1	55.5	56.0	64.5	65.9	109	16.0	16.2	16.4	22.5	23.5	25.0

Shares outstanding: 5.03m at Oct 13, 2026, from the cover of the 10-K filed Oct 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. Listed shows no prices and gives no investment advice.